{ event: "article_read", name: `Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options`, author: ``, tags: `Diabetes | Diabetes | cutting-edge-science`, publication_date: ``, interaction_type: "content" }
Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options
32% lower incidence of hypoglycemia and 46% lower incidence of hyperglycemia with ketosis at month 6 were observed with Glargine 300 in the first head to head study comparing newer generation basal insulin analog vs Glargine 100 in pediatric diabetic pts.
.png0/jcr:content/image%20(99).png)
Related articles
MAT-BH-2100831/v2/Aug 2024